For nearly 120 years, Swarovski has inspired creative talents from the world of fashion, jewelry, accessories, interior design and lighting with its brilliant crystal innovations. It seeks to push the boundaries of creativity and to bring the sparkling glamour of crystal to designer and consumer alike. Since 2002, Swarovski has exclusively provided dazzling crystals to adorn costumes and jewelry of the most glamorous events on the fashion calendar, including the Victoria’s Secret Fashion Show. This celebrated catwalk extravaganza is where lingerie, and couture meet, as the world’s most beautiful models—known as Victoria’s Secret Angels—blaze a trail down the runway.
Torax Medical announced today the publication of new data comparing the LINX® Magnetic Sphincter Augmentation Device and laparoscopic fundoplication surgery in 249 patients. Data from this study significantly adds to the growing body of evidence that the LINX device is a safe and effective procedure for patients suffering from gastro-esophageal reflux disease (GERD). Current surgical options (fundoplication) require the patient’s stomach tissue to be wrapped around the esophagus to create a barrier to reflux. The LINX device provides protection from reflux without compromising the patient’s stomach while minimizing the side effects commonly associated with the present surgical approaches.
MSD, known as Merck & Co., Inc. (NYSE:MRK) in the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development program for omarigliptin, MSD’s investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes. In a study in Japanese patients, omarigliptin provided comparable efficacy and tolerability to MSD’s once-daily DPP-4 inhibitor, JANUVIA® (sitagliptin) 50 mg, which is the standard starting dose for sitagliptin in Japan.1 MSD presented these data on omarigliptin, which has been shown to produce sustained DPP-4 inhibition, at an oral session at the 50th European Association for the Study of Diabetes (EASD) Annual Meeting.
Toys“R”Us, Inc. today announced it has strengthened its global e-commerce capabilities with the launch of a dedicated web store, Toysrus.com.cn, in China. The addition of this site represents a significant step in the company’s plans to grow its presence with physical stores and online operations in Asia. The company has also announced the development of mobile-optimized sites and apps in 11 markets around the world, including Australia, Canada, France, Germany, Japan, Spain, and the U.K. In the coming months, it will introduce the same capabilities in Portugal, Austria and Switzerland, as well as the Netherlands, where it does not currently have a store presence.
CYA Solutions Group of enChoice today announced that its CYA HOTBackup™ solution will now be resold through the EMC Direct Sales and EMC Channel Partner networks worldwide utilizing the EMC Select Program. CYA HOTBackup enhances interoperability between EMC Documentum® and existing enterprise-wide backup systems by automating hot, consistent backups of the Documentum Platform.
Terumo BCT’s customer, Europlasma GmbH, is the first blood center in Austria to receive authorization from AGES, the Austrian Agency for Health and Food Safety, to use the Mirasol Pathogen Reduction Technology System with platelets. The authorization enables the blood center to adopt an enhanced approach to blood safety, using the Mirasol system for all platelets collected for transfusion.